Received Nov 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
Bilateral nerve foot pain on the bottom of feet/ This pain has happened with previous covid injections; dizziness; weakness; This is a spontaneous report received from a Consumer or other non HCP. A 64-year-old male patient received BNT162b2 (BNT162B2), on 12Mar2021 as dose 1, single (Batch/Lot number: unknown) at the age of 64 years for covid-19 immunisation. The patient's relevant medical history included: "myelopathy" (unspecified if ongoing); "pernicious anemia" (unspecified if ongoing); "radiculopathy" (unspecified if ongoing); "lacunar infractract" (unspecified if ongoing); "shellfish allergy" (unspecified if ongoing). Concomitant medication(s) included: GABAPENTIN, start date: Aug2020. The following information was reported: NEURALGIA (non-serious) with onset 2021, outcome "not recovered", described as "Bilateral nerve foot pain on the bottom of feet/ This pain has happened with previous covid injections"; DIZZINESS (non-serious) with onset 2021, outcome "unknown"; ASTHENIA (non-serious) with onset 2021, outcome "unknown", described as "weakness". The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received.
Medical History/Concurrent Conditions: Lacunar infarction; Myelopathy; Pernicious anemia; Radiculopathy; Shellfish allergy
GABAPENTIN